These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8104720)

  • 21. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The c-erbB-2 protein in primary and metastatic breast carcinomas.
    Nesland JM; Ottestad L; Børresen AL; Tvedt KE; Holm R; Heikkilä R; Tveit K
    Ultrastruct Pathol; 1991; 15(3):281-9. PubMed ID: 1678562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.
    Wright C; Angus B; Nicholson S; Sainsbury JR; Cairns J; Gullick WJ; Kelly P; Harris AL; Horne CH
    Cancer Res; 1989 Apr; 49(8):2087-90. PubMed ID: 2564806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amplification of the c-erbB-2 gene in gastric carcinoma: correlation with survival.
    Tsugawa K; Fushida S; Yonemura Y
    Oncology; 1993; 50(6):418-25. PubMed ID: 7901825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HER2 as a prognostic factor in breast cancer.
    Ménard S; Fortis S; Castiglioni F; Agresti R; Balsari A
    Oncology; 2001; 61 Suppl 2():67-72. PubMed ID: 11694790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study.
    Gasparini G; Gullick WJ; Maluta S; Dalla Palma P; Caffo O; Leonardi E; Boracchi P; Pozza F; Lemoine NR; Bevilacqua P
    Eur J Cancer; 1994; 30A(1):16-22. PubMed ID: 7908213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors.
    González-Vela MC; Garijo MF; Fernández F; Val-Bernal JF
    Histol Histopathol; 2001 Apr; 16(2):399-406. PubMed ID: 11332695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
    van de Vijver MJ; Peterse JL; Mooi WJ; Wisman P; Lomans J; Dalesio O; Nusse R
    N Engl J Med; 1988 Nov; 319(19):1239-45. PubMed ID: 2903446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.
    Gusterson BA; Gelber RD; Goldhirsch A; Price KN; Säve-Söderborgh J; Anbazhagan R; Styles J; Rudenstam CM; Golouh R; Reed R
    J Clin Oncol; 1992 Jul; 10(7):1049-56. PubMed ID: 1351538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-erbB-2 positive breast tumours behave more aggressively in the first years after diagnosis.
    Schroeter CA; De Potter CR; Rathsmann K; Willighagen RG; Greep JC
    Br J Cancer; 1992 Oct; 66(4):728-34. PubMed ID: 1358163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammary Paget's disease and associated carcinoma. An immunohistochemical study.
    Cohen C; Guarner J; DeRose PB
    Arch Pathol Lab Med; 1993 Mar; 117(3):291-4. PubMed ID: 7680194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [C-erbB-2 oncogene amplification in breast cancer in correlation to steroid and epidermal growth factor receptor].
    Manavi M; Czerwenka KF; Zeillinger R; Speiser P; Kury F; Steinhart U; Peschke M; Kubista E; Reinold E
    Zentralbl Gynakol; 1992; 114(2):82-5. PubMed ID: 1350129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of HER-2/NEU oncoprotein in familial and non-familial breast cancer.
    Tsai KB; Hou MF; Lin HJ; Chai CY; Liu CS; Huang TJ
    Kaohsiung J Med Sci; 2001 Feb; 17(2):64-76. PubMed ID: 11416960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-erbB-2 oncoprotein amplification in infiltrating ductal carcinoma of breast relates to high histological grade and loss of oestrogen receptor protein.
    Looi LM; Cheah PL
    Malays J Pathol; 1998 Jun; 20(1):19-23. PubMed ID: 10879259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of c-erbB-2 oncoprotein in primary human tumors: an immunohistochemistry study.
    Suwanagool P; Parichatikanond P; Maeda S
    Asian Pac J Allergy Immunol; 1993 Dec; 11(2):119-22. PubMed ID: 7915904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assay of the c-erbB-2 oncogene encoded protein by ELISA and immunocytochemistry in human breast cancer.
    Nugent A; Gallagher J; Dolan J; O'Higgins N; Duffy MJ
    Ann Clin Biochem; 1994 Mar; 31 ( Pt 2)():171-3. PubMed ID: 7914719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?
    Barnes DM; Bartkova J; Camplejohn RS; Gullick WJ; Smith PJ; Millis RR
    Eur J Cancer; 1992; 28(2-3):644-8. PubMed ID: 1350456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
    Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
    Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-erbB-2 oncogene product expression depends on tumour type and is related to oestrogen receptor and lymph node status in human breast carcinoma.
    Heatley M; Maxwell P; Whiteside C; Toner PG
    Pathol Res Pract; 1993 Apr; 189(3):261-6. PubMed ID: 7687354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.